ChromoReport Summer 2019 - Utilizing a Risk-Based Approach to Contract Optimization

Tufts CSDD START II Research Report
Despite ongoing efforts to bring new treatments to market the time taken to get a clinical trial up and running hasn’t improved, with research showing that Phase II and III studies now taking a full month longer than the average seen 10 years ago.

Thorny budget and contract negotiations between sites and sponsors/CROs are the single greatest cause of delays in starting clinical trials.

But does it have to be? How could a risk-based management approach be utilized to optimize contracting?